Visual functions in epilepsy patients on valproate monotherapy

Journal of Clinical Neuroscience

Volumn 9, Issue 3, 2002, Pages 247-250

  Ozkul, Yasar ^a   Gurler, Bulent ^a   Uckardes, Ayla ^a   Bozlar, Senay ^a  

^a HARRAN UNIVERSITY   (Turkey)

Author keywords

Electroretinogram; Gamma aminobutyric acid; Seizures; Valproate; Visual acuity; Visual field

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE; 4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; VALPROIC ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROPHYSIOLOGY; ELECTRORETINOGRAM; ENZYME INHIBITION; EPILEPSY; FEMALE; HUMAN; ION TRANSPORT; MALE; NEUROLOGIC EXAMINATION; NEUROOPHTHALMOLOGY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA INJURY; SEIZURE, EPILEPSY AND CONVULSION; TREATMENT PLANNING; VISION; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT;

EID: 0036348246     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1054/jocn.2001.1015     Document Type: Article

References (29)

1. A multicenter comparative trial of sodium valproate and carbamazepine in adult epilepsy
2. Divalproex sodium in migraine prophylaxis: A dose-controlled study
3. Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy
4. Intravenous valproate loading in acutely manic and depressed bipolar I patients
5. Safety and efficacy of divalproex sodium monotherapy in partial epilepsy: A double-blind concentration-response design clinical trial
6. Gastritis with valproate therapy
7. Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients
8. The effect of sodium valproate on sleep, reaction times, and visual evoked potential in normal subjects
9. Valproate monotherapy in juvenile myoclonic epilepsy: Dose-related effects on electroencephalographic and other neurophysiologic tests
10. Sensitive physiologic perceptual tests for ocular side effects of drugs exemplified by various anticonvulsants
11. Outer retinal dysfunction in patients treated with vigabatrin
12. Severe persistent visual field constriction associated with vigabatrin
13. Severe persistent visual field constriction associated with vigabatrin. Chronic refractory epilepsy may have role in causing these unusual lesions
14. Proposal for classification of Epilepsies and Epileptic syndromes
15. Standard for clinical electroretinography
16. The development of electroretinogram abnormalities and the possible role of polyol pathway activity in diabetic hyperglycemia and galactosemia
17. Clinical studies on the oscillatory potentials of the human electroretinogram with special reference to the scotopic b-wave
18. Uptake of [H3]glycine and [H3]GABA by amacrine cells in the cat retina
19. Visual dysfunction in patients receiving vigabatrin. Clinical and electrophysiologic findings
20. Vigabatrin-associated retinal cone system dysfunction. Electroretinogram and ophthalmologic findings
21. An endogenous protein modulates the affinity of GABA and benzodiazepine receptors in rat brain
22. Attenuating effects of diazepam on the electroretinogram of normal humans
23. Vigabatrin
24. A double-blind placebo-controlled study of vigabatrin three g/day in patients with uncontrolled complex partial seizures: Vigabatrin Protocol 024 Investigative Consort
25. The new antiepileptic drugs: A systemic review of their efficacy and tolerability
26. Pattern-reversal visual evoked potentials recorded in children with generalized epilepsy
27. Severe persistent visual field constriction associated with vigabatrin. Benefit: Risk ratio must be calculated for individual patients
28. Visual field defects associated with vigabatrin therapy